R
Robert W. Laing
Researcher at Royal Surrey County Hospital
Publications - 75
Citations - 3809
Robert W. Laing is an academic researcher from Royal Surrey County Hospital. The author has contributed to research in topics: Prostate cancer & Brachytherapy. The author has an hindex of 24, co-authored 70 publications receiving 3182 citations. Previous affiliations of Robert W. Laing include Frimley Park Hospital & Institute of Cancer Research.
Papers
More filters
Journal ArticleDOI
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James,Nicholas D. James,Matthew R. Sydes,Noel W. Clarke,Malcolm David Mason,David P. Dearnaley,Melissa R. Spears,Alastair W. S. Ritchie,Chris Parker,J. Martin Russell,Gerhardt Attard,Johann S. de Bono,William Cross,Robert Jones,George N. Thalmann,Claire Amos,David Matheson,Robin Millman,Mymoona Alzouebi,Sharon Beesley,Alison Birtle,Susannah Brock,Richard Cathomas,Prabir Chakraborti,Simon Chowdhury,Audrey Cook,Tony Elliott,Joanna Gale,Stephanie Gibbs,John Graham,J. Hetherington,Robert Hughes,Robert W. Laing,Fiona McKinna,Duncan McLaren,Joe M. O'Sullivan,Omi Parikh,Clive Peedell,Andrew Protheroe,Angus Robinson,Narayanan Srihari,Rajaguru Srinivasan,John Staffurth,Santhanam Sundar,Shaun Tolan,David Tsang,John Wagstaff,Mahesh K.B. Parmar +47 more
TL;DR: Zoledronic acid showed no evidence of survival improvement and should not be part of standard of care for this population of men, and heterogeneity in treatment effect across prespecified subsets was not found.
Journal ArticleDOI
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
Nicholas D. James,Melissa R. Spears,Noel W. Clarke,David P. Dearnaley,Johann S. de Bono,Joanna Gale,J. Hetherington,Peter Hoskin,Robert Jones,Robert W. Laing,Jason F. Lester,Duncan B. McLaren,Chris Parker,Mahesh K. B. Parmar,A.W.S. Ritchie,J. Martin Russell,Räto T. Strebel,George N. Thalmann,Malcolm David Mason,Matthew R. Sydes +19 more
TL;DR: Survival remains disappointing in men presenting with M1 disease who are started on only long-term androgen deprivation therapy (ADT), despite active treatments being available at first failure of ADT.
Journal ArticleDOI
Hypofractionated stereotactic radiotherapy in the management of recurrent glioma
Stephen F. Shepherd,Robert W. Laing,Vivian P Cosgrove,Vivian P Cosgrove,A.P. Warrington,A.P. Warrington,F. Hines,Susan Ashley,Michael Brada +8 more
TL;DR: Hypofractionated SRT is a noninvasive, well-tolerated, outpatient-based method of delivering palliative, high-dose, focal irradiation in patients with recurrent glioma.
Journal ArticleDOI
A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy
TL;DR: In this paper, the authors used metformin and lifestyle intervention in men with prostate cancer with the aim of reducing the risk of developing ADT-related CV morbidity and the metabolic syndrome.
Journal ArticleDOI
Extensive transperineal template biopsies of prostate: modified technique and results.
Simon Bott,Alastair Henderson,James E. Halls,Bruce Montgomery,Robert W. Laing,Stephen E.M. Langley +5 more
TL;DR: In men with a clinical suspicion of prostate cancer, but benign or equivocal prostate biopsies, extensive transperineal template biopsy of the prostate is a useful diagnostic tool.